nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP2D6—Hydroxyurea—head and neck cancer	0.131	0.176	CbGbCtD
Methadone—CYP3A7—Docetaxel—head and neck cancer	0.0828	0.112	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0828	0.112	CbGbCtD
Methadone—CYP2C8—Fluorouracil—head and neck cancer	0.0782	0.106	CbGbCtD
Methadone—CYP3A5—Docetaxel—head and neck cancer	0.0621	0.0838	CbGbCtD
Methadone—CYP1A2—Fluorouracil—head and neck cancer	0.0605	0.0817	CbGbCtD
Methadone—CYP2C9—Fluorouracil—head and neck cancer	0.0546	0.0736	CbGbCtD
Methadone—ABCB1—Vinblastine—head and neck cancer	0.049	0.0662	CbGbCtD
Methadone—CYP2D6—Vinblastine—head and neck cancer	0.0462	0.0624	CbGbCtD
Methadone—ABCB1—Docetaxel—head and neck cancer	0.0404	0.0546	CbGbCtD
Methadone—CYP3A4—Vinblastine—head and neck cancer	0.0294	0.0397	CbGbCtD
Methadone—CYP3A4—Docetaxel—head and neck cancer	0.0242	0.0327	CbGbCtD
Methadone—CHRNA10—internal ear—head and neck cancer	0.0138	0.333	CbGeAlD
Methadone—CHRNA10—ear—head and neck cancer	0.00929	0.225	CbGeAlD
Methadone—HTR3A—cranial nerve—head and neck cancer	0.00529	0.128	CbGeAlD
Methadone—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.00432	0.0338	CcSEcCtD
Methadone—Cardiomyopathy—Fluorouracil—head and neck cancer	0.00386	0.0302	CcSEcCtD
Methadone—Lacrimation—Fluorouracil—head and neck cancer	0.00336	0.0263	CcSEcCtD
Methadone—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00313	0.0244	CcSEcCtD
Methadone—Phlebitis—Vinblastine—head and neck cancer	0.00254	0.0198	CcSEcCtD
Methadone—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00244	0.0191	CcSEcCtD
Methadone—Lacrimation—Docetaxel—head and neck cancer	0.00243	0.019	CcSEcCtD
Methadone—Disorientation—Hydroxyurea—head and neck cancer	0.00223	0.0174	CcSEcCtD
Methadone—Lacrimation increased—Fluorouracil—head and neck cancer	0.00214	0.0168	CcSEcCtD
Methadone—Redness—Docetaxel—head and neck cancer	0.00211	0.0165	CcSEcCtD
Methadone—Dermatitis contact—Fluorouracil—head and neck cancer	0.00195	0.0153	CcSEcCtD
Methadone—Rhinorrhoea—Docetaxel—head and neck cancer	0.00176	0.0138	CcSEcCtD
Methadone—CHRNA10—lymphoid tissue—head and neck cancer	0.00172	0.0416	CbGeAlD
Methadone—Euphoric mood—Fluorouracil—head and neck cancer	0.0017	0.0133	CcSEcCtD
Methadone—Swelling—Fluorouracil—head and neck cancer	0.00163	0.0127	CcSEcCtD
Methadone—Amenorrhoea—Docetaxel—head and neck cancer	0.00162	0.0127	CcSEcCtD
Methadone—Disorientation—Fluorouracil—head and neck cancer	0.0016	0.0125	CcSEcCtD
Methadone—Weight increased—Hydroxyurea—head and neck cancer	0.00157	0.0123	CcSEcCtD
Methadone—Lacrimation increased—Docetaxel—head and neck cancer	0.00155	0.0121	CcSEcCtD
Methadone—Drug interaction—Docetaxel—head and neck cancer	0.00154	0.012	CcSEcCtD
Methadone—Drowsiness—Hydroxyurea—head and neck cancer	0.00154	0.012	CcSEcCtD
Methadone—Cardiac failure—Fluorouracil—head and neck cancer	0.00147	0.0115	CcSEcCtD
Methadone—CHRNA10—head—head and neck cancer	0.00139	0.0335	CbGeAlD
Methadone—Hallucination—Hydroxyurea—head and neck cancer	0.00137	0.0107	CcSEcCtD
Methadone—Irritability—Fluorouracil—head and neck cancer	0.00137	0.0107	CcSEcCtD
Methadone—Cardiac arrest—Fluorouracil—head and neck cancer	0.00136	0.0107	CcSEcCtD
Methadone—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00128	0.01	CcSEcCtD
Methadone—Lightheadedness—Docetaxel—head and neck cancer	0.00128	0.00998	CcSEcCtD
Methadone—Pulmonary oedema—Docetaxel—head and neck cancer	0.00127	0.00993	CcSEcCtD
Methadone—Chills—Hydroxyurea—head and neck cancer	0.00124	0.00968	CcSEcCtD
Methadone—GRIN3A—head—head and neck cancer	0.00123	0.0296	CbGeAlD
Methadone—Phlebitis—Docetaxel—head and neck cancer	0.0012	0.0094	CcSEcCtD
Methadone—Erythema—Hydroxyurea—head and neck cancer	0.0012	0.00939	CcSEcCtD
Methadone—Vertigo—Vinblastine—head and neck cancer	0.00118	0.00925	CcSEcCtD
Methadone—Swelling—Docetaxel—head and neck cancer	0.00117	0.00918	CcSEcCtD
Methadone—Convulsion—Vinblastine—head and neck cancer	0.00114	0.00892	CcSEcCtD
Methadone—Visual disturbance—Docetaxel—head and neck cancer	0.00109	0.00855	CcSEcCtD
Methadone—Cardiac failure—Docetaxel—head and neck cancer	0.00106	0.0083	CcSEcCtD
Methadone—Thrombocytopenia—Vinblastine—head and neck cancer	0.00105	0.00823	CcSEcCtD
Methadone—Convulsion—Hydroxyurea—head and neck cancer	0.00104	0.00814	CcSEcCtD
Methadone—Anorexia—Vinblastine—head and neck cancer	0.00102	0.00801	CcSEcCtD
Methadone—Oedema—Hydroxyurea—head and neck cancer	0.00098	0.00766	CcSEcCtD
Methadone—CHRNA10—lymph node—head and neck cancer	0.000972	0.0235	CbGeAlD
Methadone—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000959	0.0075	CcSEcCtD
Methadone—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000946	0.0074	CcSEcCtD
Methadone—Anorexia—Hydroxyurea—head and neck cancer	0.000934	0.0073	CcSEcCtD
Methadone—Decreased appetite—Vinblastine—head and neck cancer	0.000934	0.0073	CcSEcCtD
Methadone—Nasopharyngitis—Docetaxel—head and neck cancer	0.000926	0.00724	CcSEcCtD
Methadone—Pain—Vinblastine—head and neck cancer	0.000919	0.00719	CcSEcCtD
Methadone—Constipation—Vinblastine—head and neck cancer	0.000919	0.00719	CcSEcCtD
Methadone—Arrhythmia—Fluorouracil—head and neck cancer	0.000887	0.00694	CcSEcCtD
Methadone—Feeling abnormal—Vinblastine—head and neck cancer	0.000885	0.00692	CcSEcCtD
Methadone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000879	0.00687	CcSEcCtD
Methadone—Somnolence—Hydroxyurea—head and neck cancer	0.000871	0.00681	CcSEcCtD
Methadone—Erythema—Fluorouracil—head and neck cancer	0.000864	0.00676	CcSEcCtD
Methadone—OPRD1—head—head and neck cancer	0.000864	0.0209	CbGeAlD
Methadone—Decreased appetite—Hydroxyurea—head and neck cancer	0.000852	0.00666	CcSEcCtD
Methadone—Abdominal pain—Vinblastine—head and neck cancer	0.000849	0.00664	CcSEcCtD
Methadone—CYP19A1—connective tissue—head and neck cancer	0.00084	0.0203	CbGeAlD
Methadone—Pain—Hydroxyurea—head and neck cancer	0.000838	0.00655	CcSEcCtD
Methadone—Constipation—Hydroxyurea—head and neck cancer	0.000838	0.00655	CcSEcCtD
Methadone—OPRK1—head—head and neck cancer	0.000828	0.02	CbGeAlD
Methadone—Weight increased—Docetaxel—head and neck cancer	0.000815	0.00637	CcSEcCtD
Methadone—Weight decreased—Docetaxel—head and neck cancer	0.00081	0.00633	CcSEcCtD
Methadone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000807	0.00632	CcSEcCtD
Methadone—Hypersensitivity—Vinblastine—head and neck cancer	0.000792	0.00619	CcSEcCtD
Methadone—Body temperature increased—Hydroxyurea—head and neck cancer	0.000775	0.00606	CcSEcCtD
Methadone—Asthenia—Vinblastine—head and neck cancer	0.000771	0.00603	CcSEcCtD
Methadone—Convulsion—Fluorouracil—head and neck cancer	0.000749	0.00586	CcSEcCtD
Methadone—Diarrhoea—Vinblastine—head and neck cancer	0.000735	0.00575	CcSEcCtD
Methadone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000722	0.00565	CcSEcCtD
Methadone—Confusional state—Fluorouracil—head and neck cancer	0.000711	0.00556	CcSEcCtD
Methadone—Dizziness—Vinblastine—head and neck cancer	0.00071	0.00556	CcSEcCtD
Methadone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000705	0.00552	CcSEcCtD
Methadone—Oedema—Fluorouracil—head and neck cancer	0.000705	0.00552	CcSEcCtD
Methadone—Asthenia—Hydroxyurea—head and neck cancer	0.000703	0.0055	CcSEcCtD
Methadone—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000691	0.0054	CcSEcCtD
Methadone—Visual impairment—Docetaxel—head and neck cancer	0.00069	0.0054	CcSEcCtD
Methadone—Tachycardia—Fluorouracil—head and neck cancer	0.000688	0.00538	CcSEcCtD
Methadone—Vomiting—Vinblastine—head and neck cancer	0.000683	0.00534	CcSEcCtD
Methadone—Headache—Vinblastine—head and neck cancer	0.000673	0.00526	CcSEcCtD
Methadone—Anorexia—Fluorouracil—head and neck cancer	0.000672	0.00526	CcSEcCtD
Methadone—Diarrhoea—Hydroxyurea—head and neck cancer	0.00067	0.00524	CcSEcCtD
Methadone—Flushing—Docetaxel—head and neck cancer	0.000665	0.0052	CcSEcCtD
Methadone—Hypotension—Fluorouracil—head and neck cancer	0.000659	0.00515	CcSEcCtD
Methadone—Dizziness—Hydroxyurea—head and neck cancer	0.000648	0.00507	CcSEcCtD
Methadone—Chills—Docetaxel—head and neck cancer	0.000643	0.00503	CcSEcCtD
Methadone—HTR3A—head—head and neck cancer	0.000643	0.0155	CbGeAlD
Methadone—Arrhythmia—Docetaxel—head and neck cancer	0.00064	0.00501	CcSEcCtD
Methadone—Nausea—Vinblastine—head and neck cancer	0.000638	0.00499	CcSEcCtD
Methadone—Insomnia—Fluorouracil—head and neck cancer	0.000638	0.00499	CcSEcCtD
Methadone—Somnolence—Fluorouracil—head and neck cancer	0.000627	0.0049	CcSEcCtD
Methadone—Erythema—Docetaxel—head and neck cancer	0.000624	0.00488	CcSEcCtD
Methadone—Vomiting—Hydroxyurea—head and neck cancer	0.000623	0.00487	CcSEcCtD
Methadone—Rash—Hydroxyurea—head and neck cancer	0.000618	0.00483	CcSEcCtD
Methadone—Dermatitis—Hydroxyurea—head and neck cancer	0.000617	0.00483	CcSEcCtD
Methadone—Headache—Hydroxyurea—head and neck cancer	0.000614	0.0048	CcSEcCtD
Methadone—Decreased appetite—Fluorouracil—head and neck cancer	0.000613	0.0048	CcSEcCtD
Methadone—Pain—Fluorouracil—head and neck cancer	0.000603	0.00472	CcSEcCtD
Methadone—Muscle spasms—Docetaxel—head and neck cancer	0.0006	0.00469	CcSEcCtD
Methadone—OPRM1—head—head and neck cancer	0.000589	0.0142	CbGeAlD
Methadone—Nausea—Hydroxyurea—head and neck cancer	0.000582	0.00455	CcSEcCtD
Methadone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000581	0.00455	CcSEcCtD
Methadone—Urticaria—Fluorouracil—head and neck cancer	0.00056	0.00438	CcSEcCtD
Methadone—Syncope—Docetaxel—head and neck cancer	0.000559	0.00437	CcSEcCtD
Methadone—CYP19A1—thyroid gland—head and neck cancer	0.000558	0.0135	CbGeAlD
Methadone—Body temperature increased—Fluorouracil—head and neck cancer	0.000558	0.00436	CcSEcCtD
Methadone—Palpitations—Docetaxel—head and neck cancer	0.000551	0.00431	CcSEcCtD
Methadone—Loss of consciousness—Docetaxel—head and neck cancer	0.000548	0.00429	CcSEcCtD
Methadone—Convulsion—Docetaxel—head and neck cancer	0.00054	0.00423	CcSEcCtD
Methadone—Hypersensitivity—Fluorouracil—head and neck cancer	0.00052	0.00406	CcSEcCtD
Methadone—Dry mouth—Docetaxel—head and neck cancer	0.000519	0.00406	CcSEcCtD
Methadone—Confusional state—Docetaxel—head and neck cancer	0.000513	0.00401	CcSEcCtD
Methadone—Oedema—Docetaxel—head and neck cancer	0.000509	0.00398	CcSEcCtD
Methadone—Anaphylactic shock—Docetaxel—head and neck cancer	0.000509	0.00398	CcSEcCtD
Methadone—Shock—Docetaxel—head and neck cancer	0.000501	0.00392	CcSEcCtD
Methadone—Pruritus—Fluorouracil—head and neck cancer	0.000499	0.0039	CcSEcCtD
Methadone—Thrombocytopenia—Docetaxel—head and neck cancer	0.000498	0.0039	CcSEcCtD
Methadone—Tachycardia—Docetaxel—head and neck cancer	0.000497	0.00389	CcSEcCtD
Methadone—CYP19A1—head—head and neck cancer	0.000495	0.012	CbGeAlD
Methadone—Anorexia—Docetaxel—head and neck cancer	0.000485	0.0038	CcSEcCtD
Methadone—Diarrhoea—Fluorouracil—head and neck cancer	0.000483	0.00377	CcSEcCtD
Methadone—Hypotension—Docetaxel—head and neck cancer	0.000476	0.00372	CcSEcCtD
Methadone—Dizziness—Fluorouracil—head and neck cancer	0.000466	0.00365	CcSEcCtD
Methadone—Insomnia—Docetaxel—head and neck cancer	0.00046	0.0036	CcSEcCtD
Methadone—Somnolence—Docetaxel—head and neck cancer	0.000453	0.00354	CcSEcCtD
Methadone—Vomiting—Fluorouracil—head and neck cancer	0.000448	0.00351	CcSEcCtD
Methadone—Rash—Fluorouracil—head and neck cancer	0.000445	0.00348	CcSEcCtD
Methadone—Dermatitis—Fluorouracil—head and neck cancer	0.000444	0.00347	CcSEcCtD
Methadone—Decreased appetite—Docetaxel—head and neck cancer	0.000442	0.00346	CcSEcCtD
Methadone—Headache—Fluorouracil—head and neck cancer	0.000442	0.00346	CcSEcCtD
Methadone—Pain—Docetaxel—head and neck cancer	0.000435	0.0034	CcSEcCtD
Methadone—Constipation—Docetaxel—head and neck cancer	0.000435	0.0034	CcSEcCtD
Methadone—Feeling abnormal—Docetaxel—head and neck cancer	0.000419	0.00328	CcSEcCtD
Methadone—Nausea—Fluorouracil—head and neck cancer	0.000419	0.00328	CcSEcCtD
Methadone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000416	0.00326	CcSEcCtD
Methadone—Abdominal pain—Docetaxel—head and neck cancer	0.000402	0.00315	CcSEcCtD
Methadone—Body temperature increased—Docetaxel—head and neck cancer	0.000402	0.00315	CcSEcCtD
Methadone—CYP2B6—lymphoid tissue—head and neck cancer	0.000394	0.00953	CbGeAlD
Methadone—Hypersensitivity—Docetaxel—head and neck cancer	0.000375	0.00293	CcSEcCtD
Methadone—CYP1A2—thyroid gland—head and neck cancer	0.000374	0.00903	CbGeAlD
Methadone—Asthenia—Docetaxel—head and neck cancer	0.000365	0.00286	CcSEcCtD
Methadone—Pruritus—Docetaxel—head and neck cancer	0.00036	0.00282	CcSEcCtD
Methadone—Diarrhoea—Docetaxel—head and neck cancer	0.000348	0.00272	CcSEcCtD
Methadone—CYP19A1—lymph node—head and neck cancer	0.000347	0.00838	CbGeAlD
Methadone—Dizziness—Docetaxel—head and neck cancer	0.000337	0.00263	CcSEcCtD
Methadone—Vomiting—Docetaxel—head and neck cancer	0.000324	0.00253	CcSEcCtD
Methadone—Rash—Docetaxel—head and neck cancer	0.000321	0.00251	CcSEcCtD
Methadone—Dermatitis—Docetaxel—head and neck cancer	0.000321	0.00251	CcSEcCtD
Methadone—Headache—Docetaxel—head and neck cancer	0.000319	0.00249	CcSEcCtD
Methadone—CYP2B6—head—head and neck cancer	0.000318	0.00768	CbGeAlD
Methadone—Nausea—Docetaxel—head and neck cancer	0.000302	0.00236	CcSEcCtD
Methadone—ABCB1—epithelium—head and neck cancer	0.000274	0.00662	CbGeAlD
Methadone—ABCB1—trachea—head and neck cancer	0.000242	0.00585	CbGeAlD
Methadone—CYP2D6—head—head and neck cancer	0.000236	0.00571	CbGeAlD
Methadone—ABCB1—lymphoid tissue—head and neck cancer	0.000211	0.0051	CbGeAlD
Methadone—ABCB1—thyroid gland—head and neck cancer	0.000192	0.00463	CbGeAlD
Methadone—Oxaprozin—PTGS2—head and neck cancer	0.000188	0.45	CrCbGaD
Methadone—ABCB1—head—head and neck cancer	0.00017	0.00411	CbGeAlD
Methadone—Phenylbutazone—PTGS2—head and neck cancer	0.000125	0.298	CrCbGaD
Methadone—ABCB1—lymph node—head and neck cancer	0.000119	0.00288	CbGeAlD
Methadone—Tamoxifen—CYP1A1—head and neck cancer	0.000106	0.252	CrCbGaD
Methadone—OPRK1—Signaling Pathways—GRP—head and neck cancer	7.45e-05	0.000833	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—YAP1—head and neck cancer	7.3e-05	0.000817	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STAT6—head and neck cancer	7.23e-05	0.000809	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—UROD—head and neck cancer	7.01e-05	0.000784	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	6.99e-05	0.000782	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.98e-05	0.000781	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—DPYD—head and neck cancer	6.75e-05	0.000755	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	6.7e-05	0.000749	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—NAT2—head and neck cancer	6.69e-05	0.000748	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	6.49e-05	0.000726	CbGpPWpGaD
Methadone—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	6.42e-05	0.000718	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—YAP1—head and neck cancer	6.41e-05	0.000717	CbGpPWpGaD
Methadone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	6.4e-05	0.000716	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—YAP1—head and neck cancer	6.4e-05	0.000716	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.37e-05	0.000712	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GRP—head and neck cancer	6.3e-05	0.000704	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	6.15e-05	0.000688	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STAT6—head and neck cancer	6.11e-05	0.000684	CbGpPWpGaD
Methadone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	6.07e-05	0.000679	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—DPYD—head and neck cancer	5.86e-05	0.000656	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	5.75e-05	0.000643	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—YAP1—head and neck cancer	5.56e-05	0.000622	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	5.46e-05	0.000611	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.44e-05	0.000609	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—UROD—head and neck cancer	5.41e-05	0.000605	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—YAP1—head and neck cancer	5.41e-05	0.000605	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—TYMS—head and neck cancer	5.03e-05	0.000562	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—GSTM1—head and neck cancer	4.97e-05	0.000556	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—NAT2—head and neck cancer	4.94e-05	0.000553	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.93e-05	0.000552	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—NAT2—head and neck cancer	4.83e-05	0.000541	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.81e-05	0.000539	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.76e-05	0.000533	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—GPX1—head and neck cancer	4.76e-05	0.000532	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—CYP1A1—head and neck cancer	4.71e-05	0.000527	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.45e-05	0.000497	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.4e-05	0.000492	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—DPYD—head and neck cancer	4.34e-05	0.000485	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.3e-05	0.000481	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—DPYD—head and neck cancer	4.24e-05	0.000474	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—IL2—head and neck cancer	4.22e-05	0.000472	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.2e-05	0.00047	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—NAT2—head and neck cancer	4.19e-05	0.000468	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—YAP1—head and neck cancer	4.11e-05	0.00046	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.07e-05	0.000455	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—YAP1—head and neck cancer	4.02e-05	0.00045	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.97e-05	0.000444	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.93e-05	0.00044	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.87e-05	0.000433	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.87e-05	0.000433	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—TYMS—head and neck cancer	3.85e-05	0.00043	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL2—head and neck cancer	3.83e-05	0.000429	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GSTM1—head and neck cancer	3.8e-05	0.000425	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—NAT2—head and neck cancer	3.74e-05	0.000418	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—IL2—head and neck cancer	3.7e-05	0.000414	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—DPYD—head and neck cancer	3.67e-05	0.000411	CbGpPWpGaD
Methadone—ABCB1—Metabolism—NAT2—head and neck cancer	3.65e-05	0.000408	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GPX1—head and neck cancer	3.64e-05	0.000407	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.62e-05	0.000405	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—CYP1A1—head and neck cancer	3.6e-05	0.000403	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.58e-05	0.000401	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—YAP1—head and neck cancer	3.48e-05	0.00039	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—NAT2—head and neck cancer	3.44e-05	0.000385	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—NAT2—head and neck cancer	3.41e-05	0.000381	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL2—head and neck cancer	3.36e-05	0.000376	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.36e-05	0.000376	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—TYMS—head and neck cancer	3.34e-05	0.000374	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GSTM1—head and neck cancer	3.3e-05	0.000369	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NOTCH1—head and neck cancer	3.29e-05	0.000368	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—DPYD—head and neck cancer	3.28e-05	0.000367	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.25e-05	0.000364	CbGpPWpGaD
Methadone—ABCB1—Metabolism—DPYD—head and neck cancer	3.2e-05	0.000358	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GPX1—head and neck cancer	3.16e-05	0.000354	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CYP1A1—head and neck cancer	3.13e-05	0.00035	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—IL2—head and neck cancer	3.13e-05	0.00035	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—YAP1—head and neck cancer	3.11e-05	0.000348	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.09e-05	0.000346	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—MAPK3—head and neck cancer	3.08e-05	0.000345	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.06e-05	0.000342	CbGpPWpGaD
Methadone—ABCB1—Metabolism—YAP1—head and neck cancer	3.03e-05	0.00034	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—DPYD—head and neck cancer	3.01e-05	0.000337	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—DPYD—head and neck cancer	2.99e-05	0.000334	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.96e-05	0.000331	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—MAPK1—head and neck cancer	2.93e-05	0.000328	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—EGFR—head and neck cancer	2.93e-05	0.000328	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NAT2—head and neck cancer	2.91e-05	0.000326	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NOTCH1—head and neck cancer	2.88e-05	0.000323	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—YAP1—head and neck cancer	2.86e-05	0.00032	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL2—head and neck cancer	2.84e-05	0.000318	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—YAP1—head and neck cancer	2.83e-05	0.000317	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—PIK3CA—head and neck cancer	2.8e-05	0.000313	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTGS2—head and neck cancer	2.8e-05	0.000313	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.74e-05	0.000307	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—MAPK3—head and neck cancer	2.7e-05	0.000302	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.62e-05	0.000293	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—MAPK1—head and neck cancer	2.57e-05	0.000288	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—EGFR—head and neck cancer	2.57e-05	0.000288	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—DPYD—head and neck cancer	2.55e-05	0.000286	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—PIK3CA—head and neck cancer	2.54e-05	0.000285	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—TYMS—head and neck cancer	2.47e-05	0.000276	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—PIK3CA—head and neck cancer	2.46e-05	0.000275	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTEN—head and neck cancer	2.44e-05	0.000273	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GSTM1—head and neck cancer	2.44e-05	0.000273	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NOTCH1—head and neck cancer	2.44e-05	0.000273	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—YAP1—head and neck cancer	2.42e-05	0.000271	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—TYMS—head and neck cancer	2.41e-05	0.00027	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GSTM1—head and neck cancer	2.39e-05	0.000267	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HRAS—head and neck cancer	2.35e-05	0.000263	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GPX1—head and neck cancer	2.34e-05	0.000262	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.34e-05	0.000261	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP1A1—head and neck cancer	2.32e-05	0.000259	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—AKT1—head and neck cancer	2.29e-05	0.000256	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GPX1—head and neck cancer	2.29e-05	0.000256	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—MAPK3—head and neck cancer	2.28e-05	0.000255	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.28e-05	0.000255	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL2—head and neck cancer	2.26e-05	0.000253	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP1A1—head and neck cancer	2.26e-05	0.000253	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NAT2—head and neck cancer	2.25e-05	0.000251	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—PIK3CA—head and neck cancer	2.23e-05	0.00025	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCND1—head and neck cancer	2.21e-05	0.000247	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—MAPK1—head and neck cancer	2.17e-05	0.000243	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—EGFR—head and neck cancer	2.17e-05	0.000243	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTGS2—head and neck cancer	2.14e-05	0.00024	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.13e-05	0.000238	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PTEN—head and neck cancer	2.13e-05	0.000238	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—TYMS—head and neck cancer	2.09e-05	0.000234	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—AKT1—head and neck cancer	2.08e-05	0.000232	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—PIK3CA—head and neck cancer	2.08e-05	0.000232	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTM1—head and neck cancer	2.07e-05	0.000231	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HRAS—head and neck cancer	2.06e-05	0.000231	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.04e-05	0.000228	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—AKT1—head and neck cancer	2.01e-05	0.000224	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL2—head and neck cancer	1.98e-05	0.000222	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GPX1—head and neck cancer	1.98e-05	0.000222	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—DPYD—head and neck cancer	1.97e-05	0.00022	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.96e-05	0.000219	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCND1—head and neck cancer	1.93e-05	0.000216	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—head and neck cancer	1.92e-05	0.000215	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—STAT3—head and neck cancer	1.9e-05	0.000213	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PIK3CA—head and neck cancer	1.89e-05	0.000211	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—YAP1—head and neck cancer	1.87e-05	0.000209	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTEN—head and neck cancer	1.87e-05	0.000209	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTEN—head and neck cancer	1.87e-05	0.000209	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—TYMS—head and neck cancer	1.87e-05	0.000209	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—head and neck cancer	1.86e-05	0.000208	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.86e-05	0.000208	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.85e-05	0.000206	CbGpPWpGaD
Methadone—ABCB1—Metabolism—TYMS—head and neck cancer	1.82e-05	0.000204	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—AKT1—head and neck cancer	1.82e-05	0.000204	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.82e-05	0.000204	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK3—head and neck cancer	1.82e-05	0.000204	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—head and neck cancer	1.8e-05	0.000202	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GPX1—head and neck cancer	1.77e-05	0.000198	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.75e-05	0.000196	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HRAS—head and neck cancer	1.74e-05	0.000195	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK1—head and neck cancer	1.73e-05	0.000194	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EGFR—head and neck cancer	1.73e-05	0.000194	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GPX1—head and neck cancer	1.72e-05	0.000193	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PIK3CA—head and neck cancer	1.72e-05	0.000193	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—TYMS—head and neck cancer	1.72e-05	0.000192	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.71e-05	0.000191	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—TYMS—head and neck cancer	1.7e-05	0.00019	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.7e-05	0.00019	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—AKT1—head and neck cancer	1.7e-05	0.00019	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—head and neck cancer	1.69e-05	0.000189	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.68e-05	0.000188	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL2—head and neck cancer	1.68e-05	0.000188	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STAT3—head and neck cancer	1.67e-05	0.000187	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—head and neck cancer	1.64e-05	0.000183	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GPX1—head and neck cancer	1.63e-05	0.000182	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTEN—head and neck cancer	1.62e-05	0.000182	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GPX1—head and neck cancer	1.61e-05	0.00018	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.61e-05	0.00018	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.61e-05	0.00018	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK3—head and neck cancer	1.6e-05	0.000179	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.6e-05	0.000178	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.59e-05	0.000178	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTEN—head and neck cancer	1.58e-05	0.000177	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—AKT1—head and neck cancer	1.54e-05	0.000172	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK1—head and neck cancer	1.52e-05	0.00017	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EGFR—head and neck cancer	1.52e-05	0.00017	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PIK3CA—head and neck cancer	1.5e-05	0.000168	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—TYMS—head and neck cancer	1.45e-05	0.000163	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—head and neck cancer	1.45e-05	0.000163	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.44e-05	0.000161	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.44e-05	0.000161	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—head and neck cancer	1.43e-05	0.00016	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STAT3—head and neck cancer	1.41e-05	0.000158	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—AKT1—head and neck cancer	1.41e-05	0.000157	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HRAS—head and neck cancer	1.39e-05	0.000156	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GPX1—head and neck cancer	1.38e-05	0.000154	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.38e-05	0.000154	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.36e-05	0.000153	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK3—head and neck cancer	1.35e-05	0.000151	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.35e-05	0.000151	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PIK3CA—head and neck cancer	1.32e-05	0.000148	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PIK3CA—head and neck cancer	1.32e-05	0.000147	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.31e-05	0.000147	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK1—head and neck cancer	1.28e-05	0.000144	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EGFR—head and neck cancer	1.28e-05	0.000144	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—head and neck cancer	1.27e-05	0.000143	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—AKT1—head and neck cancer	1.23e-05	0.000137	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HRAS—head and neck cancer	1.22e-05	0.000136	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTEN—head and neck cancer	1.2e-05	0.000134	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTEN—head and neck cancer	1.17e-05	0.000131	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.17e-05	0.00013	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.15e-05	0.000128	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TYMS—head and neck cancer	1.12e-05	0.000126	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.12e-05	0.000125	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CA—head and neck cancer	1.11e-05	0.000125	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.11e-05	0.000124	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—AKT1—head and neck cancer	1.08e-05	0.000121	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—head and neck cancer	1.08e-05	0.000121	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—AKT1—head and neck cancer	1.08e-05	0.00012	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GPX1—head and neck cancer	1.06e-05	0.000119	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.05e-05	0.000118	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.04e-05	0.000116	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HRAS—head and neck cancer	1.03e-05	0.000115	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTEN—head and neck cancer	1.02e-05	0.000114	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—head and neck cancer	1.02e-05	0.000114	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—head and neck cancer	9.57e-06	0.000107	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—head and neck cancer	9.49e-06	0.000106	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AKT1—head and neck cancer	9.36e-06	0.000105	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AKT1—head and neck cancer	9.1e-06	0.000102	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTEN—head and neck cancer	9.07e-06	0.000102	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTEN—head and neck cancer	8.86e-06	9.91e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CA—head and neck cancer	8.47e-06	9.48e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTEN—head and neck cancer	8.34e-06	9.34e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CA—head and neck cancer	8.28e-06	9.26e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTEN—head and neck cancer	8.27e-06	9.26e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—head and neck cancer	8.11e-06	9.07e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CA—head and neck cancer	7.17e-06	8.02e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTEN—head and neck cancer	7.07e-06	7.91e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKT1—head and neck cancer	6.92e-06	7.74e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKT1—head and neck cancer	6.76e-06	7.57e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CA—head and neck cancer	6.4e-06	7.16e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—head and neck cancer	6.26e-06	7e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CA—head and neck cancer	6.25e-06	6.99e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	5.89e-06	6.59e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKT1—head and neck cancer	5.86e-06	6.55e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CA—head and neck cancer	5.84e-06	6.53e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTEN—head and neck cancer	5.46e-06	6.1e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKT1—head and neck cancer	5.23e-06	5.85e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKT1—head and neck cancer	5.1e-06	5.71e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CA—head and neck cancer	4.99e-06	5.58e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKT1—head and neck cancer	4.81e-06	5.38e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKT1—head and neck cancer	4.77e-06	5.33e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKT1—head and neck cancer	4.07e-06	4.56e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.85e-06	4.31e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKT1—head and neck cancer	3.14e-06	3.52e-05	CbGpPWpGaD
